Response to letter Re "Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS".
- DOI
- 10.1016/j.ejca.2025.115667
- Published
- 2025-07-30
- Container
- Eur J Cancer
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2025.115667,
title = {Response to letter Re "Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS".},
author = {Gobbini E and Langlais A and Missy P and Chanoine S and Besse B and Souquet PJ and Barlesi F and Audigier-Valette C and Métivier AC and Monnet I and Hureaux J and Jeannin G and Cadranel J and Lagrange A and Tran Q and Morin F and Molinier O and Westeel V and Girard N and Moro-Sibilot D.},
year = {2025},
journal = {Eur J Cancer},
doi = {10.1016/j.ejca.2025.115667},
url = {https://doi.org/10.1016/j.ejca.2025.115667}
}RIS
TY - JOUR TI - Response to letter Re "Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS". AU - Gobbini E AU - Langlais A AU - Missy P AU - Chanoine S AU - Besse B AU - Souquet PJ AU - Barlesi F AU - Audigier-Valette C AU - Métivier AC AU - Monnet I AU - Hureaux J AU - Jeannin G AU - Cadranel J AU - Lagrange A AU - Tran Q AU - Morin F AU - Molinier O AU - Westeel V AU - Girard N AU - Moro-Sibilot D. PY - 2025 JO - Eur J Cancer DO - 10.1016/j.ejca.2025.115667 UR - https://doi.org/10.1016/j.ejca.2025.115667 ER -
APA
E, G., A, L., P, M., S, C., B, B., PJ, S., F, B., C, A., AC, M., I, M., J, H., G, J., J, C., A, L., Q, T., F, M., O, M., V, W., N, G., & D., M. (2025). Response to letter Re "Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS".. Eur J Cancer. https://doi.org/10.1016/j.ejca.2025.115667
Source records
- europe-pmc · retrieved 2026-09-27T03:35:26.280Z